Rapamycin for women: ovarian aging, menopause and what to know first

Why the ovary interests rapamycin researchers

You are born with a fixed supply of egg-containing follicles. Each month a group is recruited to start developing, and most of them are lost along the way. When the supply runs low, menopause follows. mTOR signaling is one of the switches that controls how quickly resting follicles are activated.

The idea is simple: if rapamycin slows that activation, fewer follicles would be used up each month, potentially preserving the reserve for longer. In female mice, rapamycin given for a period preserved follicle numbers and extended reproductive lifespan, and the effect was largely reversible after stopping.

Where human research stands

Researchers have begun small pilot studies giving women in their late 30s and 40s a short course of low-dose rapamycin and measuring markers of ovarian reserve, such as anti-Mullerian hormone and follicle counts on ultrasound. Early reports suggest a possible slowing of reserve decline over a few months, and larger trials have been planned.

These results are preliminary. The studies are small and short, they measure surrogate markers rather than age at menopause, and headlines about delaying menopause by years are projections, not findings. Whether any slowing translates into later menopause, better health or preserved fertility is unknown.

What the one-year PEARL trial found in women

The PEARL trial gave healthy adults weekly compounded rapamycin at 5 mg or 10 mg, or placebo, for 48 weeks. Overall and serious adverse events were similar across groups. In exploratory analyses, women taking 10 mg showed improvements in lean tissue mass and self-reported pain compared with placebo. These were secondary findings in a modest-sized trial, so they are interesting rather than conclusive, and the trial did not study ovarian function.

Effects on periods and the ovaries

The Rapamune label reports ovarian cysts and menstrual disorders, including missed periods and heavy periods, in women taking sirolimus, largely from transplant use at continuous doses. Whether low intermittent dosing causes these effects is not well studied. Tell your clinician about any change in your cycle, new pelvic pain or unusual bleeding.

Pregnancy, breastfeeding and contraception

• Sirolimus can cause fetal harm and should not be taken during pregnancy
• MedlinePlus and the label advise effective contraception before starting, during treatment and for 12 weeks after the last dose
• It is not recommended while breastfeeding
• If you are trying to conceive, rapamycin for healthy aging is not appropriate; talk with a fertility specialist instead
• Contact your clinician right away if you become pregnant while taking it or within 12 weeks of stopping

Rapamycin is not a fertility treatment

If your reserve is already low, there is no evidence rapamycin can restore it. The research question is about preservation, slowing a decline that has not yet happened, and even that is unproven. Women hoping to preserve fertility have established options, such as egg freezing, that should be discussed with a reproductive specialist.

Rapamycin or hormone therapy in perimenopause?

They do different jobs. The Menopause Society describes hormone therapy as a first-line treatment for bothersome hot flashes, with the clearest benefits when started within 10 years of menopause or before age 60, and it also helps protect bone. Rapamycin has no proven effect on hot flashes, sleep, vaginal dryness or bone in women.

If midlife symptoms are your main concern, hormone therapy, chosen after an individual discussion of benefits and risks such as clots, stroke and breast cancer, is the evidence-based starting point. Rapamycin, if used at all, is a separate and experimental longevity choice.

Questions to bring to your visit

• Is my main goal symptom relief, long-term health or something else, and does rapamycin actually address it?
• Do I need contraception, and which method works best for me?
• Which of my medicines or supplements interact with sirolimus?
• What labs should I have before starting and during treatment?
• What should I do if my cycle changes or I become pregnant?
• How will we decide whether to continue after a trial period?

Other considerations for women

• Sirolimus can raise cholesterol and triglycerides, so lipids are checked before and during treatment
• Mouth sores, acne and stomach upset are common side effects
• It interacts with many medicines and with grapefruit juice
• Infection risk, vaccine timing and surgery plans need attention

Rapamycin through HealifyMD

HealifyMD prescribes FDA-approved sirolimus for general healthy-aging goals, off-label, after a clinician reviews your history, medicines, cycle and contraception. We do not prescribe it to delay menopause or preserve fertility, which remain research questions. The price is from $99/month, confirmed at your eligibility review, with labs priced separately.